Business
Press Release Aug 06 2020
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 06, 2020, titled "Glenmark introduces higher strength (400 mg) of FabiFlu�� to reduce pill burden of COVID-19 treatment".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 06, 2020, titled \"Glenmark introduces higher strength (400 mg) of FabiFlu�� to reduce pill burden of COVID-19 treatment\". View Attachment","length":371,"tagName":"div"}]